Henry Schein, Inc. And Jaguar Animal Health Inc (NASDAQ:JAGX) Sign Exclusive Distribution Deal

1352
Jaguar Animal Health Inc

Jaguar Animal Health Inc (NASDAQ:JAGX) an animal health firm focused on commercializing and developing first-in-class gastrointestinal items for production animals, foals, and high value horses, and companion posted that it has finalized a distribution deal with Henry Schein, Inc., the globe’s premium provider of health care services and items to office-based dental, medical and animal health practitioners, for sole distribution of Jaguar’s Neonorm™ Foal items to all divisions of the U.S. equine market.

The highlights

Henry Schein’s animal health segment, Dublin employs nearly 900 team members and had FY2015 net sales amounting to $2.9 billion. With 12 intentionally positioned, advanced distribution facilities and ten inside sales centers countrywide, they consider Henry Schein Animal Health is well placed to bring an extensive selection of veterinary offerings and strategic business solutions to over 26,000 veterinary professionals countrywide.

Neonorm™ Foal is a natural, clinically-evaluated, non-drug product intended for application as an anti-diarrheal in foals. The item, which works locally in the gut and is marginally absorbed systemically, covers a proprietary, uniform botanical extract resultant from the Croton lechleri tree, which is sustainably gathered.

Neonorm™ Foal was presented at Henry Schein’s booth at the AAEP Annual Convention in Orlando in the first week of December.

Lisa Conte, Jaguar’s CEO and President, said that they are extremely thrilled to have the support of a chief companion animal health distribution firms in an attempt to drive sales of Neonorm™ Foal across the U.S. equine industry. They look forward to using the extensive exposure that Neonorm™ Foal obtained at last week’s AAEP conference and working closely with Henry Schein’s sales personnel team dedicated to the equine market.

Diarrhea is one of the most prevalent clinical issues in foals, particularly within the first month of life, and to the firm’s knowledge there are presently no commercially accessible items with anti-secretory aspects for foals. The crippling impact of dehydration that often happen as an outcome of secretory diarrhea in foals can marked quickly, precipitate negative health effects and lead in death.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.